Oral Antiplatelet Therapy in Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction, ST-Segment Elevation Myocardial Infarction, and Percutaneous Coronary Intervention: Is it Time for a Guideline Update?SAUCEDO, Jorge F.The American journal of cardiology. 2009, Vol 104, Num 5, issn 0002-9149, 4C-8C, SUPArticle

Antiplatelet and Anticoagulant Therapies in Acute Coronary SyndromesHANNA, Elias B; GLANCY, David Luke; SAUCEDO, Jorge F et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 1, pp 61-70, issn 0920-3206, 10 p.Article

Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: A multicenter, randomized trialMORRISON, Douglass A; SETHI, Gulshan; ANTAKLI, Tamim et al.Journal of the American College of Cardiology. 2001, Vol 38, Num 1, pp 143-149, issn 0735-1097Article

Differences in Treatment Patterns and Outcomes Between Hispanics and Non-Hispanic Whites Treated for ST-Segment Elevation Myocardial Infarction Results From the NCDR ACTION Registry-GWTGGUZMAN, Luis A; SHUANG LI; PINA, Ileana L et al.Journal of the American College of Cardiology. 2012, Vol 59, Num 6, pp 630-631, issn 0735-1097, 2 p.Article

Regional Patterns of Use of a Medical Management Strategy for Patients With Non―ST-Segment Elevation Acute Coronary Syndromes: Insights From the EARLY ACS TrialROE, Matthew T; WHITE, Jennifer A; MAGNUS OHMAN, E et al.Circulation. Cardiovascular quality and outcomes (Print). 2012, Vol 5, Num 2, pp 205-213, issn 1941-7713, 9 p.Article

Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: Outcome of diabetic patients in the AWESOME randomized trial and registrySEDLIS, Steven P; MORRISON, Douglass A; SAUCEDO, Jorge et al.Journal of the American College of Cardiology. 2002, Vol 40, Num 9, pp 1555-1566, issn 0735-1097, 12 p.Article

Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: Results from the Evaluation of Drug-Eluting Stents and Ischemic Events RegistryBRILAKIS, Emmanouil S; COHEN, David J; BERGER, Peter B et al.The American heart journal. 2011, Vol 161, Num 2, pp 360-366, issn 0002-8703, 7 p.Article

Outcome of patients aged ≥75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shock (SHOCK) trial : Do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?DZAVIK, Vladimir; SLEEPER, Lynn A; HOCHMAN, Judith S et al.The American heart journal. 2005, Vol 149, Num 6, pp 1128-1134, issn 0002-8703, 7 p.Article

Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trialRAJAGOPALAN, Sanjay; MOHLER, Emile III; RASMUSSEN, Henrik et al.The American heart journal. 2003, Vol 145, Num 6, pp 1114-1118, issn 0002-8703, 5 p.Article

Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME Multicenter Registry: Comparison With the randomized clinical trialMORRISON, Douglass A; SETHI, Gulshan; SAUCEDO, Jorge et al.Journal of the American College of Cardiology. 2002, Vol 39, Num 2, pp 266-273, issn 0735-1097Article

Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registryGIRI, Satyendra; ITO, Shigenori; OESTERLE, Stephen et al.Catheterization and cardiovascular interventions. 2001, Vol 52, Num 1, pp 24-34, issn 1522-1946Article

Characteristics and in-hospital outcomes of patients presenting with non―ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: Stratification according to renal functionHANNA, Elias B; CHEN, Anita Y; ROE, Matthew T et al.The American heart journal. 2012, Vol 164, Num 1, pp 52-57, issn 0002-8703, 6 p.Article

Left Ventricular Ejection Fraction Assessment Among Patients With Acute Myocardial Infarction and Its Association With Hospital Quality of Care and Evidence-Based Therapy UseMILLER, Amy Leigh; DIB, Chadi; LI LI et al.Circulation. Cardiovascular quality and outcomes (Print). 2012, Vol 5, Num 5, pp 662-671, issn 1941-7713, 10 p.Article

Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trialZEFENG ZHANG; MAHONEY, Elizabeth M; GERSHONY, Gary et al.The American heart journal. 2001, Vol 142, Num 6, pp 982-988, issn 0002-8703Article

Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarctionPALMERI, Sebastian T; LOWE, April M; SLEEPER, Lynn A et al.The American journal of cardiology. 2005, Vol 96, Num 8, pp 1042-1049, issn 0002-9149, 8 p.Article

Incidence and time course of thrombocytopenla with Abciximab and Eptifibatide in patients undergoing percutaneous coronary interventionFAHDI, Ibrahim E; SAUCEDO, Jorge F; HENNEBRY, Thomas et al.The American journal of cardiology. 2004, Vol 93, Num 4, pp 453-455, issn 0002-9149, 3 p.Article

Inhibition of platelet aggregation with Eptifibatide, Bivalirudin, and Heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (the pharmacodynamic evaluation of angiomax, clopidogrel with or without integrilin [DEACON] study)SAUCEDO, Jorge F; AUDE, Wady; PACHECO, Rebecca et al.The American journal of cardiology. 2005, Vol 95, Num 12, pp 1453-1456, issn 0002-9149, 4 p.Article

Troponin Criteria for Myocardial Infarction After Percutaneous Coronary InterventionNOVACK, Victor; PENCINA, Michael; COHEN, David J et al.Archives of internal medicine (1960). 2012, Vol 172, Num 6, pp 502-508, issn 0003-9926, 7 p.Article

Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network RegistryFOX, Caroline S; MUNTNER, Paul; CHEN, Anita Y et al.Circulation (New York, N.Y.). 2010, Vol 121, Num 3, pp 357-365, issn 0009-7322, 9 p.Article

Brodycardia during therapy for multiple myeloma with ThalidomideFAHDI, Ibrahim Elias; GADDAM, Venkat; BARLOGIE, Bart et al.The American journal of cardiology. 2004, Vol 93, Num 8, pp 1052-1055, issn 0002-9149, 4 p.Article

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 TrialANGIOLILLO, Dominick J; BADIMON, Juan Jose; SAUCEDO, Jorge F et al.European heart journal. 2011, Vol 32, Num 7, pp 838-846, issn 0195-668X, 9 p.Article

Use of Emergency Medical Service Transport Among Patients With ST-Segment―Elevation Myocardial Infarction: Findings From the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry―Get With the GuidelinesMATHEWS, Robin; PETERSON, Eric D; SHUANG LI et al.Circulation (New York, N.Y.). 2011, Vol 124, Num 2, pp 154-163, issn 0009-7322, 10 p.Article

Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes: Results of the SWAP (Switching Anti Platelet) StudyANGIOLILLO, Dominick J; SAUCEDO, Jorge F; DERAAD, Roger et al.Journal of the American College of Cardiology. 2010, Vol 56, Num 13, pp 1017-1023, issn 0735-1097, 7 p.Article

Regional angiogenesis with Vascular Endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudicationRAJAGOPALAN, Sanjay; MOHLER, Emile R; ANNEX, Brian H et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 16, pp 1933-1938, issn 0009-7322, 6 p.Article

Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: Insights from the switching anti-platelet (SWAP) studySAUCEDO, Jorge F; ANGIOLILLO, Dominick J; DERAAD, Roger et al.Thrombosis and haemostasis. 2013, Vol 109, Num 2, pp 347-355, issn 0340-6245, 9 p.Article